Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InnovAge Holding Corp INNV

Healthcare Drug Manufacturers - Major
InnovAge Holding Corp. is a healthcare delivery platform. The Company is focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. The Company's programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its Program of All-Inclusive Care for the Elderly... see more

Recent & Breaking News (NDAQ:INNV)

Innovus Pharma Expands Exclusive License and Distribution Agreement with Densmore for Zestra® to Singapore and Vietnam

Business Wire July 26, 2017

Innovus Pharma Announces Combined Launch of Apeaz™ Cream for Arthritis Pain Relief, and ArthriVarx™, a Supplement Designed to Maximize and Support Joint Health

Business Wire July 24, 2017

Innovus Pharma’s Partner Luminarie Receives Approval for Zestra® for Female Sexual Arousal Disorder as a Medical Device I from Australia’s Therapeutic Goods Administration

Business Wire July 20, 2017

Innovus Joins Eli Lilly and Novartis in the Race to Develop Products for Oncology (Cachexia) -- SECFilings.com

Marketwired June 13, 2017

Innovus Pharma to Enter the Oncology Supportive Care Market With an Exclusive License to Two GRAS-Listed OTC Compounds for Cachexia and Muscle Growth and Repair From the University of Iowa Research Foundation

Business Wire June 6, 2017

Innovus Pharma Announces Positive Pre-Clinical Synergistic Effects of Vesele® in Combination with Sildenafil (Viagra®) on Nitric Oxide Production

Business Wire June 1, 2017

Innovus Pharma Launches AllerVarx, a Clinically Proven Supplement for the Relief of Allergy Symptoms, in the United States

Business Wire May 24, 2017

Innovus Pharma Signs Exclusive License and Distribution Agreement with Luminarie in Australia, New Zealand and the Philippines for Zestra® for Female Sexual Arousal Disorder and Zestra Glide® for Female Lubrication

Business Wire May 22, 2017

Innovus Makes Strides Toward Goal of Tripling Revenue in 2017 -- SECFilings.com

Marketwired May 19, 2017

Innovus Pharma Files Its Product License Application in Canada for the Commercialization of Vesele® as a Natural Health Product to Help Improve Symptoms of Sexual Dysfunction

Business Wire May 18, 2017

Innovus Pharma Signs Exclusive License and Distribution Agreement with Densmore for Zestra® in France and Belgium for Female Sexual Arousal Disorder

Business Wire May 16, 2017

Innovus Pharmaceuticals Reports Quarterly Revenue for the First Quarter 2017 of $2.2 Million

Business Wire May 12, 2017

Innovus Fast Tracks FlutiCare Commercialization with New Hikma Partnership -- SECFilings.com

Marketwired May 11, 2017

Innovus Pharma Announces Commercial Partnership to Launch FlutiCare™ Under FDA Approved ANDA No. 207957

Business Wire May 9, 2017

Innovus Pharmaceuticals to Release First Quarter 2017 Financial Results and Provide Corporate Update on Friday, May 12, 2017

Business Wire May 3, 2017

Innovus Pharma Launches ProstaGorx™ Product for Prostate Health Through its Beyond Human® Sales and Marketing Platform in the United States

Business Wire May 1, 2017

Innovus Pharmaceuticals Receives Patent for Its Sensum+® Product in Morocco

Business Wire April 12, 2017

Innovus Pharma Announces Receipt of Notification to Commercialize Zestra Glide® in the European Union

Business Wire April 5, 2017

Innovus Pharmaceuticals Announces Receipt of Notice of Intention to Grant Sensum+® European Patent

Business Wire March 27, 2017

Innovus Pharmaceuticals Announces the Cash Redemption of All Outstanding Convertible Notes

Business Wire March 22, 2017